Urinary Retention Rates in Clinical Practice After Treatment With OnabotulinumtoxinA for Idiopathic Overactive Bladder



Status:Active, not recruiting
Conditions:Overactive Bladder
Therapuetic Areas:Gastroenterology
Healthy:No
Age Range:18 - Any
Updated:4/21/2016
Start Date:August 2015
End Date:July 2016

Use our guide to learn which trials are right for you!

This study is a retrospective chart review of patients treated with BOTOX® for idiopathic
Overactive Bladder (OAB) as standard of care in clinical practice. The study will determine
the rate of post procedural urinary retention requiring catheterization and identify factors
that may predict urinary retention.


Inclusion Criteria:

-Patients treated with BOTOX® for Overactive Bladder.

Exclusion Criteria:

- Received botulinum toxin formulations other than BOTOX® in the bladder.

- Had symptoms of OAB associated with a neurological condition.

- Had a history of chronic urinary retention treated with Clean Intermittent
Catheterization (CIC) or indwelling catheter.
We found this trial at
7
sites
2500 Metrohealth Dr
Cleveland, Ohio 44109
(216) 778-7800
MetroHealth Med Ctr The MetroHealth System is one of the largest, most comprehensive health care...
?
mi
from
Cleveland, OH
Click here to add this to my saved trials
?
mi
from
Charlotte, NC
Click here to add this to my saved trials
Davis, California 95616
?
mi
from
Davis, CA
Click here to add this to my saved trials
Greensboro, North Carolina
?
mi
from
Greensboro, NC
Click here to add this to my saved trials
Irvine, California 92612
?
mi
from
Irvine, CA
Click here to add this to my saved trials
Richmond, Virginia 23233
?
mi
from
Richmond, VA
Click here to add this to my saved trials
?
mi
from
Winston-Salem, NC
Click here to add this to my saved trials